Bright Green Corporation (BGXX)
OTCMKTS
· Delayed Price · Currency is USD
0.0801
+0.0001 (0.13%)
Nov 22, 2024, 4:00 PM EST
Bright Green Employees
Bright Green had 5 employees as of December 31, 2023. The number of employees decreased by 18 or -78.26% compared to the previous year.
Employees
5
Change (1Y)
-18
Growth (1Y)
-78.26%
Revenue / Employee
n/a
Profits / Employee
-$1,805,656
Market Cap
15.33M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5 | -18 | -78.26% |
Dec 31, 2022 | 23 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Sandoz Group AG | 22,633 |
Telix Pharmaceuticals Limited | 234 |
Elekta AB (publ) | 4,718 |
Ryman Healthcare Limited | 7,700 |
Verano Holdings Corp. | 3,900 |
Vireo Growth Inc. | 490 |
Medexus Pharmaceuticals Inc. | 82 |
Bright Green News
- 2 months ago - Cannabis Companies Delisted From Major Stock Exchanges In 2024: What Went Wrong? - Benzinga
- 2 months ago - Bright Green Corporation Provides an Update, Reinforces Commitment to Shareholders, and Focuses on Growth and Strategic Partnerships - GlobeNewsWire
- 3 months ago - BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA OPERATIONS, LLC. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY. - GlobeNewsWire
- 3 months ago - Bright Green To Supply DEA-Approved Cannabis Extracts And Psychedelics To FDA-Registered Pharmaceutical Company - Benzinga
- 3 months ago - BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY. - GlobeNewsWire
- 3 months ago - BRIGHT GREEN ANNOUNCES IT HAS OBTAINED A $3.5 MILLION FUNDING COMMITMENT UNDER AN EXISTING LINE OF CREDIT AND HAS ENGAGED AN INVESTMENT BANK TO SEEK A $15.0 MILLION DEBT FINANCING TO MOVE FORWARD WITH COMMERCIALIZATION. - GlobeNewsWire
- 6 months ago - CEO UPDATE - GlobeNewsWire
- 9 months ago - BRIGHT GREEN ANNOUNCES ITS EXPANSION CONTINUATION WITH A $100 MILLION SOLAR POWERED GENERATION FIELD TO SUPPLY HEAT AND ELECTRICITY TO ITS DRUG PRODUCTION AND MANUFACTURING FACILITY. - GlobeNewsWire